Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CBMG $21.99 1.5900 +7.79%
CYTK $4.07 0.2100 +5.44%
FATE $5.51 0.2800 +5.35%
RDHL $13.90 0.5500 +4.12%
MEIP $6.79 0.1600 +2.41%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

NYMX $4.11 -0.6399 -13.47%
ENZN $1.16 -0.1000 -7.94%
OGXI $2.79 -0.2100 -7.00%
BIND $8.96 -0.6000 -6.28%
AVEO $1.12 -0.0700 -5.88%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

Fish Oil Seems to Help Cancer Patients Preserve Muscle

(MSN) Feb 28, 2011 - Cancer patients undergoing chemotherapy may be able to avoid the accompanying muscle loss and malnutrition by taking fish oil supplements that contain omega-3 fatty acids, new research suggests.
read article 

Higher Vitamin D Intake Could Cut Cancer Risk

(Bloomberg Businessweek) Feb 27, 2011 - A new study says it takes far more vitamin D than initially thought to dramatically cut the risk of several major diseases, including breast cancer.
read article 

Cellceutix Makes Breakthrough in Cancer Research by Activating p53, the Guardian Angel of the Human

(Cellceutix) Feb 28, 2011 - Cellceutix Corporation announced today that data from research on Kevetrin™, the Company's flagship compound against cancers, has demonstrated the potential for a major breakthrough in cancer research by exhibiting an activation of p53. p53, often referred to as the "Guardian Angel Gene" or the "Guardian Angel of the Human Genome" due its crucial role in controlling cell mutations, is a tumor suppressor protein that is encoded by the TP53 gene in humans and has been widely regarded as possibly holding a key to the future of cancer therapies.
read press release 

Pediatricians Group Urges a Ban on Teens at Tanning Salons

(TIME Healthland Blog) Feb 28, 2011 - Bad news for GTL'ers-in-training: the American Academy of Pediatrics (AAP) wants to ban teens from using UV tanning beds.
read article 

Pioneers in the U.S. and Canada Found Navigators Helped Boost Cancer Survival Rates, Quality of Care

(Vancouver Sun) Feb 26, 2011 - Patient navigators owe their creation, title and roles to New York cancer surgeon Dr. Harold Freeman.
read article 

Opinion: The FDA and Slower Cures

(Wall Street Journal) Feb 28, 2011 - The White House now claims it is so alarmed about declining private pharmaceutical research that the government must create a new multibillion-dollar R&D center. Perhaps it should consult the Food and Drug Administration, which thinks it is approving too many new drugs, especially for serious diseases like cancer.
read article (paid subscription required) 

Big Pharma, Meet Big Biotech

(WSJ VC Blog) Feb 25, 2011 - Venture firms traditionally have seen big pharmaceutical companies as the most likely buyers for their biotechnology start-ups, but lately they’ve been selling more of them to pharma’s smaller biotech rivals.
read article (paid subscription required) 

Synta Announces Encouraging Preliminary Results for Ganetespib (STA-9090) in Phase 2 Non-small Cell Lung Cancer Trial

(Yahoo! Finance) Feb 26, 2011 - Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that encouraging preliminary results of a Phase 2 trial of ganetespib as a single agent in non-small cell lung cancer (NSCLC) were presented at the International Association for the Study of Lung Cancer (IASLC) 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
read article 

Lance Armstrong Campaigns for Tobacco Tax Initiative to Fund Cancer Research

(Los Angeles Times) Feb 27, 2011 - Seven-time Tour de France winner Lance Armstrong will launch a campaign in support of the California Cancer Research Act, which would add a $1 tax to tobacco products.
read article (free registration required) 

Olympic Champion Using Her Cancer to Educate Women

(Washington Post) Feb 25, 2011 - With a toddler on the verge of walking, a busy work schedule and the holidays approaching, the last thing Shannon Miller really had time for was her annual checkup. Maybe, she thought, she'd cancel it, reschedule it once things calmed down.
read article (free registration required) 

ASGE: Screening Can Help Stop Colorectal Cancer Before It Starts

(Yahoo! Finance) Feb 28, 2011 - March is National Colorectal Cancer Awareness Month and the American Society for Gastrointestinal Endoscopy (ASGE), representing the doctors who specialize in colorectal cancer screening, is encouraging people to talk with their doctor about getting screened if they are age 50 and over.
read article 

Governors Scramble to Rein In Medicaid

(Wall Street Journal) Feb 28, 2011 - More than half the states want permission to remove hundreds of thousands of people from the Medicaid insurance program, a move that would represent a rare cut to a national social program.
read article (paid subscription required) 

Defining 'Essential' Care

(Wall Street Journal) Feb 28, 2011 - Maggie Haslam's five-year-old autistic son, Drew, has undergone intense behavioral, physical and speech therapy that helped him learn to dress himself and communicate such concepts as "over" and "under."
read article (paid subscription required) 

Regeneron Announces Strong Results In Gout Study

(Forbes The Medicine Show Blog) Feb 28, 2011 - Regeneron Pharmaceuticals of Tarrytown, N.Y., announced positive results from a second late-stage clinical trial showing that its drug Arcalyst, currently approved for a rare disease, can treat gout, a much more lucrative opportunity.
read article 

FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder

(Yahoo! Finance) Feb 25, 2011 - GlaxoSmithKline today announced that the United States Food and Drug Administration (FDA) granted full approval for PROMACTA® (eltrombopag), an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
read article 

Genentech Gets U.S. Hearing on Avastin, Breast Cancer

(Reuters) Feb 24, 2011 - Genentech has won a second chance to convince U.S. regulators that its Avastin drug is a safe and effective treatment for breast cancer.
read article 

Herceptin 'Cuts Chance of Breast Cancer Relapse'

(The Telegraph UK) Feb 25, 2011 - Taking the breast cancer drug Herceptin significantly reduces the chance of the disease returning over at least four years, a study has found.
read article 

Newer Drug May Help Prevent Fracture in Men With Prostate Cancer

(U.S. News & World Report) Feb 25, 2011 - A new drug called denosumab (Xgeva) performed somewhat better than the current standard treatment of zoledronic acid (Zometa) for preventing fractures and other bone problems in men with hormone-resistant prostate cancer, a new study suggests.
read article 

Study: PSA Rise Not Good Prostate Cancer Predictor

(Washington Post) Feb 24, 2011- A rising PSA level isn't such a good predictor of prostate cancer after all and can lead to many unnecessary biopsies, says a large new study.
read article (free registration required) 

Many Dialysis Patients at Risk for High Radiation Exposure

(Bloomberg Businessweek) Feb 24, 2011 - A large number of dialysis patients are at increased risk of cancer due to high radiation doses, and doctors should think about reducing these patients' levels of radiation exposure, a new study suggests.
read article 

Cut Red Meat to Lower Cancer Risk

(USA Today) Feb 25, 2011 - Bringing home the bacon might not be such a great idea, according to stricter new dietary advice from the British government issued Friday.
read article 

Pivotal Study Validates Roche’s cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer

(Roche) Feb 25, 2011- ATHENA study shows the cobas HPV Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancer.
read press release 

Helix BioPharma Corp. Files European Clinical Trial Application for a Phase I/II Study of Its Lung Cancer Drug Candidate L-DOS47

(StreetInsider) Feb 24, 2011 - Helix BioPharma Corp is seeking approval to perform its planned Phase I/II clinical safety, tolerability and preliminary efficacy study of its lung cancer drug candidate L-DOS47.
read article 

Elan, Celgene Settle Suit Over Breast Cancer Drug

(Reuters) Feb 24, 2011 - Elan Corp Plc and Celgene Corp on Thursday said they settled a patent infringement lawsuit over Celgene breast cancer drug Abraxane.
read article 

Samsung to Set Up Biomedicine Venture, Make Rituxan Copies

(Bloomberg Businessweek) Feb 25, 2011 - Samsung Group, the South Korean company whose businesses range from electronics to ship-building, will partner with Quintiles Transnational Corp. to make biologic drugs as it seeks new businesses to drive growth.
read article